User:Mr. Ibrahem/Ansuvimab

Ansuvimab, sold under the brand name Ebanga, is a medication used to treat Ebola due to Zaire ebolavirus. It may be used at any age, including during pregnancy. It is given by injection into a vein.

Common side effects include fever, fast heart rate, diarrhea, vomiting, low blood pressure. Other side effects may include allergic reactions. Use around the same time as the live Ebola vaccine, may decrease the vaccine's effectiveness. It is a monoclonal antibody that attaches to the Zaire ebolavirus glycoprotein.

Ansuvimab was approved for medical use in the United States in 2020. It is on the World Health Organization's List of Essential Medicines. It was originally made by the National Institutes of Health (NIH) who licensed it to Ridgeback Biotherapeutics to manufacture. The Biomedical Advanced Research and Development Authority (BARDA) has provided nearly USD 11 million for further development.